{"nct_id":"NCT05950334","title":"FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2023-11-16","start_date_type":"ACTUAL","primary_completion_date":"2025-06-06","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["FATE"]}